Real-World Evidence on Surgical Intervention Rates for Pacemaker Lead Dysfunction: Tendril STS vs. Other Leads - LEADconnection

Real-World Evidence on Surgical Intervention Rates for Pacemaker Lead Dysfunction: Tendril STS vs. Other Leads

Posted on November 22nd, 2022
Bookmark
ClosePlease login

Bruce Wilkoff, MD, Director of Cardiac Pacing and Tachyarrhythmia Devices, Electrophysiology & Pacing, Cleveland Clinic

Dr. Bruce Wilkoff presents the study cohort, methodology and results of a study comparing long term lead related complication free survival rates between the Abbott Tendril STS model 2088 pacemaker leads and non-Abbott pacemaker leads for single chamber and dual chamber pacemakers.

This study utilized EP PASSION real world methodology. EP PASSION is a partnership between the FDA, physician societies, academia and CIED device manufacturers to develop mechanisms to quantify long-term pacemaker/defibrillator lead performance.

Presented at APHRS2022, Singapore, November 18-20, 2022.

Learn more about EP PASSION methodology:

  • Dhruva SS, Zeitler EP, Caños D, Odobasic H, Major JM, Wang L, Mullane S, Nabutovsky Y, Smith V, Zhang L, Selzman KA. Evaluation of cardiovascular implantable electronic device leads post implant: ElectroPhysiology Predictable And SuStainable Implementation Of National Registries (EP PASSION). J Interv Card Electrophysiol. 2022 Mar 25. doi: 10.1007/s10840-022-01189-x. Epub ahead of print. PMID: 35334060.
  • EP PASSION poster